Galecto, Inc. — Director's Dealing 2021

May 28, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Galecto, Inc. (GLTO)
CIK: 0001800315
Period of Report: 2021-05-26

Reporting Person: Khuong Chau Quang (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-05-26	Stock Option (right to buy)	$4.93	A	18000	Acquired	2031-05-25	Common Stock (18000)	Direct

Footnotes

F1: Pursuant to the Issuer's Non-Employee Director Compensation Policy, this option was automatically granted on May 26, 2021, the date of the Issuer's 2021 Annual Meeting of Stockholder, with shares subject to the option vesting in equal monthly installments until the first anniversary of the grant date. Pursuant to an agreement with OrbiMed Advisors LLC, OrbiMed Capital GP VII LLC, OrbiMed Advisors Israel II Limited, and OrbiMed Israel GP II, L.P., the Reporting Person is obligated to transfer any securities issued under any such stock options or other awards, or the economic benefit thereof, to OrbiMed Advisors LLC, OrbiMed Capital GP VII LLC, OrbiMed Advisors Israel II Limited, and OrbiMed Israel GP II, L.P., which will in turn ensure that such securities or economic benefits are provided to OrbiMed Private Investments VII, L.P. and OrbiMed Israel Partners II, L.P.